DILTIA XT Trademark

Trademark Overview


On Thursday, January 16, 1997, a trademark application was filed for DILTIA XT with the United States Patent and Trademark Office. The USPTO has given the DILTIA XT trademark a serial number of 75226586. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 22, 2021. This trademark is owned by Andrx Pharmaceuticals, Inc.. The DILTIA XT trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations containing diltiazem hydrochloride for use in the treatment of cardiovascular disorders

General Information


Serial Number75226586
Word MarkDILTIA XT
Filing DateThursday, January 16, 1997
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 22, 2021
Registration Number2184954
Registration DateTuesday, August 25, 1998
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 21, 1997

Trademark Statements


Goods and Servicespharmaceutical preparations containing diltiazem hydrochloride for use in the treatment of cardiovascular disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 22, 2021
Primary Code005
First Use Anywhere DateFriday, October 10, 1997
First Use In Commerce DateFriday, October 10, 1997

Trademark Owner History


Party NameWATSON PHARMACEUTICALS, INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressPARSIPPANY, NJ 07054

Party NameANDRX PHARMACEUTICALS, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressDavie, FL 33314

Party NameAndrx Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFort Lauderdale, FL 33314

Party NameAndrx Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFort Lauderdale, FL 33314

Party NameAndrx Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFort Lauderdale, FL 33314

Trademark Events


Event DateEvent Description
Friday, October 22, 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Wednesday, January 11, 2012AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, June 23, 2010CASE FILE IN TICRS
Sunday, May 30, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, March 14, 2009REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, March 14, 2009REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, March 3, 2009ASSIGNED TO PARALEGAL
Wednesday, February 25, 2009TEAS SECTION 8 & 9 RECEIVED
Wednesday, April 9, 2008ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, July 29, 2004REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, June 21, 2004REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, August 25, 1998REGISTERED-PRINCIPAL REGISTER
Wednesday, July 1, 1998ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 26, 1998ASSIGNED TO EXAMINER
Monday, June 22, 1998STATEMENT OF USE PROCESSING COMPLETE
Friday, June 5, 1998USE AMENDMENT FILED
Tuesday, January 13, 1998NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 21, 1997PUBLISHED FOR OPPOSITION
Friday, September 19, 1997NOTICE OF PUBLICATION
Wednesday, August 13, 1997APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 5, 1997EXAMINER'S AMENDMENT MAILED
Friday, August 1, 1997ASSIGNED TO EXAMINER